What is the immunotherapy drug Opdivo (nivolumab,) how does it work, what cancers is it approved for, and what are the common side effects?
Yervoy is an immunotherapy used to treat melanoma, colorectal cancer, liver cancer, non-small cell lung cancer, kidney cancer, and mesothelioma.
Learn about how immunotherapy is being used to treat advanced non-small cell lung cancer, including the science behind three specific drugs.
Adjuvant therapy for melanoma is treatment sometimes used after surgery to reduce the risk of recurrence. Learn about the types, benefits, and side effects.
Learn how immunotherapies are emerging as promising therapies for certain head and neck cancers, including how they work and their safety profile.
The term durable response is used to describe a prolonged response to cancer treatment. Learn what it means, when it may occur, and with what cancers.
Treatments for kidney cancer may include surgery (nephrectomy), targeted therapies, immunotherapy, or clinical trials looking at newer and better therapies.
Hyper-progression is a condition in which cancer grows faster after treatment with immunotherapy. Learn why it may occur and what it means for you.
Immunotherapy for lung cancer treats patients with drugs that help the immune system better respond and fight off some kinds of lung cancer.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.